Lian Li

Title: Lian Li: Innovator in Factor VIII Research

Introduction

Lian Li is a prominent inventor based in Lexington, MA (US), known for his significant contributions to the field of biotechnology. He holds a total of 6 patents, focusing primarily on Factor VIII and its applications in medical treatments.

Latest Patents

Lian Li's latest patents include innovative methods and compositions related to Factor VIII. One of his notable inventions is the "Factor VIII chimeric and hybrid polypeptides, and methods of use thereof." This invention provides methods for administering processed FVIII, single chain FVIII, or a combination thereof. It also includes chimeric and hybrid polypeptides comprising Factor VIII, polynucleotides encoding these polypeptides, and methods for producing them using specific cells. Another significant patent is the "Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof," which similarly outlines methods for administering Factor VIII and related polypeptides.

Career Highlights

Throughout his career, Lian Li has worked with notable companies in the biotechnology sector, including Bioverativ Therapeutics Inc. and Biogen Idec Hemophilia Inc. His work has significantly advanced the understanding and treatment of hemophilia, showcasing his dedication to improving patient outcomes.

Collaborations

Lian Li has collaborated with esteemed colleagues such as Jennifer A Dumont and Susan C Low, contributing to a rich environment of innovation and research in his field.

Conclusion

Lian Li's contributions to Factor VIII research and his innovative patents have made a lasting impact in biotechnology. His work continues to influence the development of treatments for hemophilia and related disorders.